ZECLINICS NEWS

ZeClinics and University of Messina enter into agreement to launch a joint Industrial PhD Program in Veterinary Sciences

model-human-glioma-in-zebrafish ZECLINICS NEWS

Conclusion of ZF-Glioma project

Logo_cardiomyo_project ZECLINICS NEWS

ZeClinics, Amsterdam UMC and Taros Chemicals join forces to boost drug discovery for cardiomyopathies

Gb_sciences_logo ZECLINICS NEWS

Statistical Significance in Preclinical Study of Cannabinoid formulations against Parkinson’s Disease in Zebrafish

ZECLINICS NEWS

The Use of Zebrafish Genetics in Eradicating Diseases

ZECLINICS NEWS

Magnolia bark compound discovered to potentially treat drug-resistant epilepsy

ZeClinics DZNE Agreement ZECLINICS NEWS

ZeClinics Partners with German Center for Neurodegenerative Diseases (DZNE)

ZECLINICS NEWS

ZeCardio Therapeutics, spin-out de ZeClinics, abre su ronda de crowdfunding

ZeClinics GRINpatias ZECLINICS NEWS

ZeClinics une esfuerzos con IDIBELL para el estudio de las GRINpatias

CIRSPR CAS 9 ZECLINICS NEWS

Study shows that CRISPR-Cas9 gene editing has a low risk of mistakes in Zebrafish

CNIC HEART REANIMA ZECLINICS NEWS

REANIMA: towards the new horizon of cardiac regeneration

ZECLINICS NEWS

New insights in thalidomide teratogenicity

ZECLINICS NEWS

Zebrafish earn their drug discovery stripes

ZECLINICS NEWS

Increasing the Efficiency of Drug Discovery by Combining Zebrafish and CRISPR/Cas9

Drug Discovery ZECLINICS NEWS

ZeClinics uses Zebrafish for Drug Discovery and Biomedical Research

ZeClinics_SEAZIT ZECLINICS NEWS

ZeClinics has been selected to perform an essential inter-laboratory study sponsored by SEAZIT